Norbert W Bischofberger Kronos Bio, Inc. (KRON) insider trading activity

Norbert W Bischofberger is PRESIDENT & CEO of Kronos Bio, Inc.. Currently has a direct ownership of 2.81 Million shares of KRON, which is worth approximately $2.64 Million. The most recent transaction as insider was on Feb 15, 2024, when has been sold 270,339 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.81M

0% 3M change

10.64% 12M change

Total Value Held $2.64 Million

NORBERT W BISCHOFBERGER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 15 2024	BUY Grant, award, or other acquisition	-	270,339 Added 8.77%	2,811,004 Common Stock
Nov 17 2023	BUY Open market or private purchase	$105,769 $1.08 p/Share	97,935 Added 3.71%	2,540,665 Common Stock
Nov 16 2023	BUY Open market or private purchase	$262,433 $1.0 p/Share	262,433 Added 9.7%	2,442,730 Common Stock
Nov 15 2023	BUY Open market or private purchase	$1,096,550 $0.8 p/Share	1,370,688 Added 38.6%	2,180,297 Common Stock
May 19 2022	BUY Open market or private purchase	$1,134,000 $3.78 p/Share	300,000 Added 27.04%	809,609 Common Stock
May 18 2022	BUY Open market or private purchase	$767,057 $3.72 p/Share	206,198 Added 28.81%	509,609 Common Stock
May 17 2022	BUY Open market or private purchase	$348,266 $3.83 p/Share	90,931 Added 23.06%	303,411 Common Stock
Dec 06 2021	BUY Open market or private purchase	$173,564 $12.09 p/Share	14,356 Added 6.33%	212,480 Common Stock
Dec 10 2020	BUY Grant, award, or other acquisition	-	198,124 Added 50.0%	198,124 Common Stock

Also insider at

MORF

Morphic Holding, Inc. Healthcare

VIR

Vir Biotechnology, Inc. Healthcare

Director

NWB